Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ XETRA) stock market data APIs
€16.855
0.06(0.4%)
as of October 29, 2025
Try our APIs with
free plan!
Eckert & Ziegler Strahlen- und Medizintechnik AG Financial Data Overview
Price chart is built with
Anychart
Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; ophthalmological products; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, consumables, therapeutic products and plant engineering, and other services. It offers standard and radiation sources for medical and industrial sectors; medical imaging and spect diagnostics, industrial analytical and instrument, high activity CS-137 and CO-60, and oil well logging sources; blood irradiators and environmental disposal source services; and bulk isotopes as well as calibration related sources for radioisotopes. It serves medical, scientific, and industrial applications. The company was formerly known as Eckert & Ziegler Strahlen- und Medizintechnik AG and changed its name to Eckert & Ziegler SE in March 2024. Eckert & Ziegler SE was founded in 1992 and is headquartered in Berlin, Germany.
Prev. Close
16.855
Open
16.9103
High
17.1626
Low
16.9103
52 wk Range
12.1725-23.2499
Market Cap
1 054 M
P/E Ratio
25.5303
Shares Outstanding
62 567 K
Revenue
299 M
EPS
0.56
Dividends (Yield)
0.001
Beta
1.546
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Eckert & Ziegler Strahlen- und Medizintechnik AG (top by weight)
Ticker
100-day Price Change
Weight
IS0S.F
iShares III Public Limited Company - iShares Emerging Asia Local Government Bond UCITS ETF
-0.61
(-0.81%)
0.00
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Eckert & Ziegler Strahlen- und Medizintechnik AG data using free add-ons & libraries
Get Eckert & Ziegler Strahlen- und Medizintechnik AG Fundamental Data
Eckert & Ziegler Strahlen- und Medizintechnik AG Fundamental data includes:
- Net Revenue: 299 M
- EBITDA: 81 700 K
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Eckert & Ziegler Strahlen- und Medizintechnik AG Earnings data
$
19.99
/mo.
What’s included:
- Latest Release: 2025-08-08
- EPS/Forecast: NaN
Get Eckert & Ziegler Strahlen- und Medizintechnik AG End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Eckert & Ziegler Strahlen- und Medizintechnik AG News
![[Latest] Global Radiopharmaceutical CDMO Market Size/Share Worth USD 7.2 Billion by 2034 at a 9.3% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)](/build/assets/fallback6-Bl1ei6Q_.jpg)
New
[Latest] Global Radiopharmaceutical CDMO Market Size/Share Worth USD 7.2 Billion by 2034 at a 9.3% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Radiopharmaceutical CDMO Market size & share ...
Exploring Three Undiscovered European Gems With Potential
As European markets navigate a complex landscape of interest rate policies and trade uncertainties, the pan-European STOXX Europe 600 Index remains steady, reflecting cautious investor sentiment. Amid...
Here's Why We Think Eckert & Ziegler (ETR:EUZ) Is Well Worth Watching
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story even if these companies are loss-making. Sometimes these stories can cloud the mind...
Eckert & Ziegler (ETR:EUZ) jumps 5.3% this week, though earnings growth is still tracking behind three-year shareholder returns
It hasn't been the best quarter for Eckert & Ziegler SE (ETR:EUZ) shareholders, since the share price has fallen 22% in that time. But at least the stock is up over the last three years. Arguably you'...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
